QIAGEN powered by

Webinars and events

« All Events

  • This event has passed.

Make discoveries from public data (GEO, SRA and more) using QIAGEN Ingenuity Pathway Analysis

April 13, 2023 @ 1:00 pm - 2:30 pm

You asked for it, and we’re here to deliver. We are hosting a comprehensive training on effectively using sample-level public data and metadata from sources like GEO, SRA, TCGA, GTEx, Blueprint, CCLE and others through QIAGEN Ingenuity Pathway Analysis (IPA) and the IPA Analysis Match Explorer feature. We’ll walk you through use cases involving biomarker discovery, drug target investigation, studying survival in custom patient cohorts, multi-gene correlation and more.

We’ll cover topics like:
• How is a gene of interest expressed across different conditions?(‘conditions’ refers to diseases, disease subtypes, treatments, cell types, cell lines and more)
• Is there a correlation in expression for two genes or biomarkers of user interest for a given condition?
• Can we compare more than two genes in a heatmap?
• For a given condition of interest, can we derive a list of genes (for example, genes specific to a disease, treatment or cell type)?
• Can we generate custom cohorts of patients (for example, TP53 wt vs. mutant or PDCD1 high vs. low expression) and then create survival curves representing those cohorts? Can we generate a p-value to see if there is a significant difference?
• Can we detect the expression of a gene in different cell types from single-cell data?

Register for event

Details

Date: April 13, 2023
Time:
 1:00 pm - 2:30 pm
Register for event

Venue:

Virtual – Americas – EST
United States
View Venue Website
Event Categories:
,
Event Tags:
,

Venue

Virtual – Americas – EST
United States

Other

Category
Discovery, Webinar

Related Events

Register for event

On-demand Webinars


  • Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity Pathway Analysis

    Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the impact of a new drug that has already been through the arduous R&D process for a disease or cancer. Drug repurposing can take this concept and expand on it by looking for other diseases with similar drug target biology. The logic is if...

    WATCH NOW
  • Part I: Single-cell RNA sequencing data analysis using QIAGEN CLC Genomics Workbench

    This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators and cell type signatures within your data. This session is for part I of this training. In this session, you'll learn to use QIAGEN CLC Genomics Workbench to perform se...

    WATCH NOW
  • Part II: Single-cell RNA sequencing data interpretation using QIAGEN Ingenuity Pathway Analysis

    This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators and cell type signatures within your data. In this session, we'll explore how you can take your scRNA-seq differential expression results produced from QIAGEN CLC Genom...

    WATCH NOW
  • Immune repertoire analysis using QIAGEN CLC Genomics Workbench

    The composition of the immune repertoire, consisting of the T cell and B cell receptors (TCR and BCR), is important for an organism's adaptive immune system and plays a pivotal role in an individual's overall health. Understanding the complex array of TCR and BCR allows for developing precision medicine and immunotherapy. Analyzing next-generation sequencing (NGS) dat...

    WATCH NOW
  • Compare and contextualize your results using QIAGEN Ingenuity Pathway Analysis

    Take your QIAGEN Ingenuity Pathway Analysis (IPA) analyses to the next level by comparing them to your own analyses (different time points, treatments, cell lines, diseases and more) or to a library of over 100K precomputed datasets to find similar or opposite biological signatures. Identify key genes or entities and then explore how they are expressed across normal t...

    WATCH NOW
  • Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft

    In this 90-minute training, you'll learn how to perform drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands. Using public data from GTEx (normal tissue), GEO, cancer collections and more, you'll learn how to use Omicsoft Lands to: • Investigate a drug target or biom...

    WATCH NOW
Sample to Insight